The free coverage is for type 2 diabetes only and needs prior authorization. Walmart won't pay when the drugs are prescribed just for weight loss.
Recap by typeshit. Full story at BigGo Finance.
Canada is one of the first big markets where semaglutide goes off patent. IQVIA plans ongoing updates on pricing, coverage and generic uptake.
The estimate, shared by M Mohan, starts from about $141 billion in 2025, with North America holding roughly 62% and semaglutide and tirzepatide leading.
The Medicare GLP-1 Bridge pilot runs July 2026 through 2027, covering FDA-approved pills and shots with no deductible for eligible Part D enrollees.
The two drugs brought in $14.9 billion of Lilly's $23.0 billion fiscal Q2 revenue while US prices fell 9%, Trefis says. The Q3 report is expected around October 29.
Researchers identified the patient groups most likely to benefit before starting treatment, giving employers a clinical basis for coverage as costs climb.
She describes her routine as lots of little decisions, like checking yogurt labels for protein, rather than one big change.
Loading…